Company / R&D Expense
Xencor Inc R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$239.4M
FY2025
5-year range
$118.6M / $253.6M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#74 of 210
Health Care
What the data says
At $239M, Xencor Inc's r&d expense ranks #74 of 210 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $52M in FY2018 to $254M in FY2023.
Based on SEC 10-K filings.
$239M in FY2025 with a 5-year CAGR of +7.1%.
Declined from $254M to $239M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
#74 of 210 in Health CareTop 35% of 210This company $239.4M Sector average $644.1M
▼
-62.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.1%, indicating consistent growth.
- In FY2025, r&d expense increased 5.2% year-over-year.
- Ranks #74 out of 210 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $239.4M | +5.2% |
| FY2024 | $227.7M | -10.2% |
| FY2023 | $253.6M | +27.1% |
| FY2022 | $199.6M | +68.3% |
| FY2021 | $118.6M | -30.2% |
| FY2020 | $169.8M | +136.6% |
| FY2019 | $71.8M | +38.4% |
| FY2018 | $51.9M | -27.7% |
| FY2017 | $71.8M | +38.4% |
| FY2016 | $51.9M | +51.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026